SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bacil Pharma - Quaterly Results

14 Feb 2026 Evaluate
The revenue for the December 2025 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended December 2025 of Rs. 0.39 millions grew from Rs.-0.62 millions Operating profit Margin for the quarter ended December 2025 improved to 0.39% as compared to -0.62% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.64 0.03 2033.33 11.21 5.74 95.30 6.61 1.31 404.58
PBIDT 0.39 -0.62 -162.90 9.51 3.93 141.98 4.08 -0.57 -815.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.39 -0.62 -162.90 9.51 3.93 141.98 4.08 -0.57 -815.79
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 -50.00
PBT 0.39 -0.62 -162.90 9.51 3.93 141.98 4.07 -0.59 -789.83
TAX 0.00 0.00 0.00 2.30 0.03 7566.67 0.03 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.03 0.00 0.03 0.00 0.00
PAT 0.39 -0.62 -162.90 7.21 3.90 84.87 4.04 -0.59 -784.75
Equity 139.70 58.90 137.18 139.70 58.90 137.18 139.70 58.90 137.18
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bacil Pharma Share Price

56.99 2.00 (3.64%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×